Dr. Andreas Stelzl is an expert in biopharmaceutical drug product development, with over eight years of hands-on experience advancing innovative therapies from pre-clinical stages to commercialization. Currently serving as Client Project Manager at Coriolis Pharma, he has led numerous high-value projects focused on the formulation and optimization of complex biologics. Dr. Stelzl’s work spans the full spectrum of drug product development, from designing high concentration liquid formulations and evaluating advanced delivery systems to implementing robust analytical methods for biopharmaceutical characterization. His scientific expertise is complemented by a strong track record in project management and team leadership, ensuring the successful delivery of high-quality drug products that meet both client and regulatory expectations. Dr. Stelzl earned his PhD in Pharmaceutical Technology and Biopharmacy from Ludwig-Maximilians-Universität München, where his research contributed to industry-leading advancements in formulation science.